- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Recurrent Genital Herpes
Total 25184 results
-
BayerRecruiting
-
ImmunoGen, Inc.RecruitingFallopian Tube Cancer | Endometrial Cancer | Primary Peritoneal Carcinoma | High Grade Serous Adenocarcinoma of OvaryUnited States
-
University of OklahomaGlaxoSmithKlineRecruitingRecurrent Ovarian Carcinoma | Recurrent Endometrial Carcinoma | ARID1A Gene MutationUnited States
-
Zin W MyintArtemiLifeRecruiting
-
Haider MahdiMerck Sharp & Dohme LLC; ALX OncologyRecruiting
-
Yonsei UniversityRecruitingOvarian CancerKorea, Republic of
-
Qilu Pharmaceutical Co., Ltd.RecruitingMETASTATIC CERVICAL CANCERChina
-
ImmunoGen, Inc.GOG FoundationRecruitingOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States, Korea, Republic of, Spain, Australia, Canada, United Kingdom, Italy, Czechia, Philippines, Israel, Belgium
-
Sichuan Cancer Hospital and Research InstituteNot yet recruiting
-
Yonsei UniversityRecruitingRecurrent Epithelial Ovarian CancerKorea, Republic of
-
BioNTech SERecruiting
-
Kaiser PermanentePatient-Centered Outcomes Research InstituteRecruitingMaternal Morbidity | Racial Disparities | Genital Herpes SimplexUnited States
-
Zhongda HospitalNot yet recruitingOvarian Cancer, EpithelialChina
-
Second Affiliated Hospital of Guangzhou Medical...RecruitingStage IV Ovarian Cancer | Endometrial Cancer Recurrent | Testis Cancer, Refractory | CAR NKChina
-
Zhongnan HospitalBinhui Biopharmaceutical Co., Ltd.RecruitingUterine Cervical NeoplasmsChina
-
Peking Union Medical College HospitalZai Lab (Shanghai) Co., Ltd.Not yet recruiting
-
Fondazione del Piemonte per l'OncologiaNational Cancer Institute (NCI); University of Pisa; Royal Marsden NHS Foundation... and other collaboratorsRecruitingProstate Cancer | Prostate Cancer Recurrent | Prostate Cancer Metastatic | Prostate Cancer AggressivenessItaly
-
Universitaire Ziekenhuizen KU LeuvenRecruitingProstate Cancer | Metastatic Cancer | Prostate Cancer Recurrent | Prostate Cancer Metastatic | Oligometastasis | Oligometastatic Disease | Hormone Sensitive Prostate CancerBelgium
-
Hugh TaylorRecruitingAsherman Syndrome | Recurrent Implantation Failure | Atrophic EndometriumUnited States
-
University Health Network, TorontoRecruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingPlatinum-resistant Recurrent Ovarian CancerChina
-
H. Lee Moffitt Cancer Center and Research InstituteAnixa Biosciences, Inc.RecruitingOvarian CancerUnited States
-
National Cancer Center, KoreaRecruitingEpithelial Ovarian CancerKorea, Republic of
-
Lei LiRecruitingChemotherapy | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Niraparib | Anlotinib | CA125 | Targeted Therapy | Recurrent Ovarian CancerChina
-
Lei LiRecruitingRecurrent Ovarian Carcinoma | Platinum-resistant Ovarian Cancer | Bevacizumab | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Albumin-bound PaclitaxelChina
-
Columbia UniversityJanssen PharmaceuticalsRecruitingRecurrent Prostate CancerUnited States
-
Chongqing University Cancer HospitalRecruitingOvarian NeoplasmsChina
-
Genelux CorporationGOG FoundationRecruitingFallopian Tube Cancer | Platinum-resistant Ovarian Cancer | Platinum-refractory Ovarian Cancer | Primary Peritoneal Cancer | High-grade Serous Ovarian Cancer | Endometrioid Ovarian Cancer | Ovarian Clear Cell CarcinomaUnited States
-
Loyola UniversityMedical University of South Carolina; Cures Within ReachRecruitingOvarian CancerUnited States
-
West China Second University HospitalNot yet recruitingRecurrent Ovarian CancerChina
-
National Cancer Institute, NaplesRecruiting
-
Zhejiang Cancer HospitalRecruiting
-
Zhejiang Cancer HospitalNot yet recruitingUterine Cervical Neoplasms | Oncolytic Virotherapy | CamrelizumabChina
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Celldex TherapeuticsRecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Endometrial Serous Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Platinum-Sensitive Ovarian Carcinoma | Recurrent Fallopian... and other conditionsUnited States
-
The Affiliated Hospital of Xuzhou Medical UniversityXuzhou Medical University; IIT MediTech (Jiangsu) Co. LtdRecruiting
-
Haider MahdiDr. Reddys Laboratories, SARecruitingEpithelial Ovarian CancerUnited States
-
The Second Affiliated Hospital of Shandong First...Recruiting
-
The Netherlands Cancer InstituteUMC Utrecht; Advanced Accelerator ApplicationsRecruiting
-
Kosei Hasegawa, MD, PhDRecruitingCarcinoma, Ovarian EpithelialJapan
-
GOG FoundationNovartisRecruitingEndometroid Endometrial CancerUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingRecurrent Platinum-resistant Ovarian CancerChina
-
The First Affiliated Hospital of Zhengzhou UniversityNot yet recruitingCervical Cancer
-
AGO Research GmbHGlaxoSmithKlineNot yet recruitingPrimary Peritoneal Cancer | Recurrent Ovarian Cancer | Recurrent Fallopian Tube Cancer
-
M.D. Anderson Cancer CenterRecruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruiting
-
Sarah K. Lynam MDBayerRecruitingOvarian Cancer | Serous Ovarian CancerUnited States
-
National Cancer Institute (NCI)NRG OncologyRecruitingEndometrial Clear Cell Adenocarcinoma | Endometrial Dedifferentiated Carcinoma | Endometrial Endometrioid Adenocarcinoma | Endometrial Mixed Cell Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Recurrent Endometrial Carcinoma | Endometrial Adenocarcinoma | Endometrioid Adenocarcinoma | Endometrial...United States
-
National Cancer Institute (NCI)RecruitingMucosal Melanoma | Anal Melanoma | Bladder Melanoma | Cervical Melanoma | Esophageal Melanoma | Gallbladder Melanoma | Mucosal Melanoma of the Head and Neck | Mucosal Melanoma of the Urinary System | Oral Cavity Mucosal Melanoma | Penile Mucosal Melanoma | Rectal Melanoma | Recurrent Mucosal Melanoma | Sinonasal... and other conditionsUnited States, Canada
-
The Affiliated Hospital of the Chinese Academy...Recruiting
-
Mark SteinRecruitingRecurrent Prostate CancerUnited States